The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...

According to the FDA, 1 each of the unapproved products were sold on the firm’s websites, Amazon shops, and social media ...

Colorado can better address the opioid crisis and equip organizations like IFC on the Hill with the tools to save lives.

The Food and Drug Administration has approved Unloxcyt (cosibelimab-ipdl) for advanced cutaneous squamous cell carcinoma.